https://www.selleckchem.com/pr....oducts/4-phenylbutyr
228, n=536, p.0001, Spearman's rho=0.265, n=536, p.0001). There was no significant difference in rates of missed cancers between the 452 readers who exceeded the 1500 first read per year target and those who did not (t(94.2)=-1.87, p=.0643, r=0.19). The use of a test-set based assessment scheme accurately reflects real-life mammography reading performance, indicating that it can be a useful tool in identifying poor reader performance. The use of a test-set based assessment scheme accurately reflects real-life
Like
Comment
Share
